CT-005404

CT-005404, or CT-5404, is an atypical dopamine reuptake inhibitor (DRI) that was derived from modafinil.^[1][2][3] It shows pro-motivational effects in animals and reverses motivational deficits induced by tetrabenazine and interleukin-1β.^[2][4][3] CT-005404 is described as being orally active in animals and having a long duration of action.^[5][4][3] It is under development by Chronos Therapeutics for treatment of motivational disorders.^[6][3] The drug was first described by 2018.^[5][1][6][3]

CT-005404

Clinical data
Other names	CT-5404
Drug class	Atypical dopamine reuptake inhibitor; Pro-motivational agent

See also

• List of modafinil analogues and derivatives
• MRZ-9547
• PRX-14040